Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Mai 2012 10:24 ET | Quelle: IMMUNE Pharmaceuticals

IMMUNE Pharmaceuticals Announces Strategic Partnership With the World-Renowned Weizmann Institute

HERZLIYA and REHOVOT, Israel, May 23, 2012 (GLOBE NEWSWIRE) -- IMMUNE Pharmaceuticals, an emerging leader in the development of monoclonal antibodies, and Yeda, the technology transfer company of the...
26. April 2012 08:00 ET | Quelle: IMMUNE Pharmaceuticals

Myrtle Potter & Company is Retained by IMMUNE Pharmaceuticals as Business Development Advisor for NanomAb Drug Conjugates Portfolio

SAN JOSE, Calif. and HERZLIYA, Israel, April 26, 2012 (GLOBE NEWSWIRE) -- Myrtle Potter & Company announced today that it has been retained by IMMUNE Pharmaceuticals as an advisor for their...
30. Januar 2012 08:30 ET | Quelle: IMMUNE Pharmaceuticals

IMMUNE Pharmaceuticals Granted US$1 Million (NIS 3.8M) by the Office of the Chief Scientist in Israel

HERZLIYA, Israel and NEW YORK, Jan. 30, 2012 (GLOBE NEWSWIRE) -- IMMUNE Pharmaceuticals, an emerging leader in the development of monoclonal antibody based therapeutics for the treatment of...